Table 13.
Histology | Total | Male | Female | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
5-Year Total | Annual Average | Rate | 95% CI | 5-Year Total | Annual Average | Rate | 95% CI | 5-Year Total | Annual Average | Rate | 95% CI | |
Tumors of Neuroepithelial Tissue | 15,742 | 3,148 | 3.82 | 3.77-3.88 | 8,488 | 1,698 | 4.04 | 3.95-4.12 | 7,254 | 1,451 | 3.60 | 3.52-3.69 |
Pilocytic astrocytoma | 3,746 | 749 | 0.91 | 0.88-0.94 | 1,954 | 391 | 0.93 | 0.89-0.97 | 1,792 | 358 | 0.89 | 0.85-0.93 |
Diffuse astrocytoma | 998 | 200 | 0.24 | 0.23-0.26 | 534 | 107 | 0.25 | 0.23-0.28 | 464 | 93 | 0.23 | 0.21-0.25 |
Anaplastic astrocytoma | 405 | 81 | 0.10 | 0.09-0.11 | 220 | 44 | 0.10 | 0.09-0.12 | 185 | 37 | 0.09 | 0.08-0.11 |
Unique astrocytoma variants | 511 | 102 | 0.12 | 0.11-0.14 | 290 | 58 | 0.14 | 0.12-0.15 | 221 | 44 | 0.11 | 0.10-0.13 |
Malignant | 247 | 49 | 0.06 | 0.05-0.07 | 141 | 28 | 0.07 | 0.06-0.08 | 106 | 21 | 0.05 | 0.04-0.06 |
Non-Malignant | 264 | 53 | 0.06 | 0.06-0.07 | 149 | 30 | 0.07 | 0.06-0.08 | 115 | 23 | 0.06 | 0.05-0.07 |
Glioblastoma | 759 | 152 | 0.18 | 0.17-0.20 | 408 | 82 | 0.19 | 0.18-0.21 | 351 | 70 | 0.17 | 0.16-0.19 |
Oligodendroglioma | 191 | 38 | 0.05 | 0.04-0.05 | 99 | 20 | 0.05 | 0.04-0.06 | 92 | 18 | 0.05 | 0.04-0.06 |
Anaplastic oligodendroglioma | 28 | 6 | 0.01 | 0.00-0.01 | - | - | - | - | - | - | - | - |
Oligoastrocytic tumors | 105 | 21 | 0.03 | 0.02-0.03 | 50 | 10 | 0.02 | 0.02-0.03 | 55 | 11 | 0.03 | 0.02-0.04 |
Ependymal tumors | 1,216 | 243 | 0.29 | 0.28-0.31 | 670 | 134 | 0.32 | 0.29-0.34 | 546 | 109 | 0.27 | 0.25-0.29 |
Malignant | 1,022 | 204 | 0.25 | 0.23-0.26 | 567 | 113 | 0.27 | 0.25-0.29 | 455 | 91 | 0.23 | 0.21-0.25 |
Non-Malignant | 194 | 39 | 0.05 | 0.04-0.05 | 103 | 21 | 0.05 | 0.04-0.06 | 91 | 18 | 0.04 | 0.04-0.05 |
Glioma malignant, NOS | 2,799 | 560 | 0.68 | 0.66-0.71 | 1,412 | 282 | 0.67 | 0.64-0.71 | 1,387 | 277 | 0.69 | 0.65-0.73 |
Choroid plexus tumors | 406 | 81 | 0.10 | 0.09-0.11 | 230 | 46 | 0.11 | 0.10-0.12 | 176 | 35 | 0.09 | 0.07-0.10 |
Malignant | 101 | 20 | 0.02 | 0.02-0.03 | 54 | 11 | 0.03 | 0.02-0.03 | 47 | 9 | 0.02 | 0.02-0.03 |
Non-Malignant | 305 | 61 | 0.07 | 0.07-0.08 | 176 | 35 | 0.08 | 0.07-0.10 | 129 | 26 | 0.06 | 0.05-0.08 |
Other neuroepithelial tumors | 32 | 6 | 0.01 | 0.01-0.01 | - | - | - | - | 27 | 5 | 0.01 | 0.01-0.02 |
Malignant | 27 | 5 | 0.01 | 0.00-0.01 | - | - | - | - | 24 | 5 | 0.01 | 0.01-0.02 |
Non-Malignant | - | - | - | - | - | - | - | - | - | - | - | - |
Neuronal and mixed neuronal-glial tumors | 1,787 | 357 | 0.43 | 0.41-0.45 | 987 | 197 | 0.47 | 0.44-0.50 | 800 | 160 | 0.40 | 0.37-0.43 |
Malignant | 89 | 18 | 0.02 | 0.02-0.03 | 54 | 11 | 0.03 | 0.02-0.03 | 35 | 7 | 0.02 | 0.01-0.02 |
Non-Malignant | 1,698 | 340 | 0.41 | 0.39-0.43 | 933 | 187 | 0.44 | 0.41-0.47 | 765 | 153 | 0.38 | 0.35-0.41 |
Tumors of the pineal region | 212 | 42 | 0.05 | 0.04-0.06 | 104 | 21 | 0.05 | 0.04-0.06 | 108 | 22 | 0.05 | 0.04-0.06 |
Malignant | 174 | 35 | 0.04 | 0.04-0.05 | 92 | 18 | 0.04 | 0.04-0.05 | 82 | 16 | 0.04 | 0.03-0.05 |
Non-Malignant | 38 | 8 | 0.01 | 0.01-0.01 | - | - | - | - | 26 | 5 | 0.01 | 0.01-0.02 |
Embryonal tumors | 2,547 | 509 | 0.62 | 0.60-0.64 | 1,510 | 302 | 0.72 | 0.68-0.76 | 1,037 | 207 | 0.52 | 0.48-0.55 |
Medulloblastoma c | 1,617 | 323 | 0.39 | 0.38-0.41 | 1,027 | 205 | 0.49 | 0.46-0.52 | 590 | 118 | 0.29 | 0.27-0.32 |
Primitive neuroectodermal tumor d | 311 | 62 | 0.08 | 0.07-0.08 | 162 | 32 | 0.08 | 0.07-0.09 | 149 | 30 | 0.07 | 0.06-0.09 |
Atypical teratoid rhabdoid tumor e | 388 | 78 | 0.09 | 0.08-0.10 | 201 | 40 | 0.10 | 0.08-0.11 | 187 | 37 | 0.09 | 0.08-0.11 |
Other embryonal histologies f | 231 | 46 | 0.06 | 0.05-0.06 | 120 | 24 | 0.06 | 0.05-0.07 | 111 | 22 | 0.05 | 0.05-0.07 |
Tumors of Cranial and Spinal Nerves | 1,286 | 257 | 0.31 | 0.29-0.33 | 672 | 134 | 0.32 | 0.29-0.34 | 614 | 123 | 0.30 | 0.28-0.33 |
Nerve sheath tumors | 1,283 | 257 | 0.31 | 0.29-0.33 | 669 | 134 | 0.32 | 0.29-0.34 | 614 | 123 | 0.30 | 0.28-0.33 |
Malignant | 23 | 5 | 0.01 | 0.00-0.01 | - | - | - | - | - | - | - | - |
Non-Malignant | 1,260 | 252 | 0.31 | 0.29-0.32 | 659 | 132 | 0.31 | 0.29-0.34 | 601 | 120 | 0.30 | 0.27-0.32 |
Other tumors of cranial and spinal nerves | - | - | - | - | - | - | - | - | - | - | - | - |
Tumors of Meninges | 1,116 | 223 | 0.27 | 0.25-0.28 | 551 | 110 | 0.26 | 0.24-0.28 | 565 | 113 | 0.28 | 0.26-0.30 |
Meningioma | 668 | 134 | 0.16 | 0.15-0.17 | 318 | 64 | 0.15 | 0.13-0.17 | 350 | 70 | 0.17 | 0.15-0.19 |
Malignant | 33 | 7 | 0.01 | 0.01-0.01 | - | - | - | - | 21 | 4 | 0.01 | 0.01-0.02 |
Non-Malignant | 635 | 127 | 0.15 | 0.14-0.16 | 306 | 61 | 0.14 | 0.13-0.16 | 329 | 66 | 0.16 | 0.14-0.18 |
Mesenchymal tumors | 231 | 46 | 0.06 | 0.05-0.06 | 123 | 25 | 0.06 | 0.05-0.07 | 108 | 22 | 0.05 | 0.04-0.06 |
Primary melanocytic lesions | - | - | - | - | - | - | - | - | - | - | - | - |
Other neoplasms related to the meninges | 207 | 41 | 0.05 | 0.04-0.06 | 103 | 21 | 0.05 | 0.04-0.06 | 104 | 21 | 0.05 | 0.04-0.06 |
Lymphomas and Hematopoietic Neoplasms | 121 | 24 | 0.03 | 0.02-0.04 | 79 | 16 | 0.04 | 0.03-0.05 | 42 | 8 | 0.02 | 0.01-0.03 |
Lymphoma | 59 | 12 | 0.01 | 0.01-0.02 | 40 | 8 | 0.02 | 0.01-0.03 | 19 | 4 | 0.01 | 0.01-0.01 |
Other hematopoietic neoplasms | 62 | 12 | 0.02 | 0.01-0.02 | 39 | 8 | 0.02 | 0.01-0.03 | 23 | 5 | 0.01 | 0.01-0.02 |
Germ Cell Tumors and Cysts | 910 | 182 | 0.22 | 0.21-0.24 | 630 | 126 | 0.30 | 0.28-0.32 | 280 | 56 | 0.14 | 0.12-0.16 |
Germ cell tumors, cysts and heterotopias | 910 | 182 | 0.22 | 0.21-0.24 | 630 | 126 | 0.30 | 0.28-0.32 | 280 | 56 | 0.14 | 0.12-0.16 |
Malignant | 708 | 142 | 0.17 | 0.16-0.19 | 525 | 105 | 0.25 | 0.23-0.27 | 183 | 37 | 0.09 | 0.08-0.11 |
Non-Malignant | 202 | 40 | 0.05 | 0.04-0.06 | 105 | 21 | 0.05 | 0.04-0.06 | 97 | 19 | 0.05 | 0.04-0.06 |
Tumors of Sellar Region | 3,850 | 770 | 0.92 | 0.89-0.95 | 1,231 | 246 | 0.58 | 0.55-0.61 | 2,619 | 524 | 1.28 | 1.24-1.33 |
Tumors of the pituitary | 3,002 | 600 | 0.72 | 0.69-0.74 | 798 | 160 | 0.37 | 0.35-0.40 | 2,204 | 441 | 1.08 | 1.03-1.12 |
Malignant | - | - | - | - | - | - | - | - | - | - | - | - |
Non-Malignant | 2,999 | 600 | 0.72 | 0.69-0.74 | 797 | 159 | 0.37 | 0.35-0.40 | 2,202 | 440 | 1.08 | 1.03-1.12 |
Craniopharyngioma | 848 | 170 | 0.21 | 0.19-0.22 | 433 | 87 | 0.21 | 0.19-0.23 | 415 | 83 | 0.21 | 0.19-0.23 |
Unclassified Tumors | 1,507 | 301 | 0.36 | 0.35-0.38 | 719 | 144 | 0.34 | 0.32-0.37 | 788 | 158 | 0.39 | 0.36-0.42 |
Hemangioma | 599 | 120 | 0.14 | 0.13-0.16 | 284 | 57 | 0.13 | 0.12-0.15 | 315 | 63 | 0.16 | 0.14-0.17 |
Neoplasm, unspecified | 882 | 176 | 0.21 | 0.20-0.23 | 423 | 85 | 0.20 | 0.18-0.22 | 459 | 92 | 0.23 | 0.21-0.25 |
Malignant | 212 | 42 | 0.05 | 0.04-0.06 | 109 | 22 | 0.05 | 0.04-0.06 | 103 | 21 | 0.05 | 0.04-0.06 |
Non-Malignant | 670 | 134 | 0.16 | 0.15-0.17 | 314 | 63 | 0.15 | 0.13-0.17 | 356 | 71 | 0.18 | 0.16-0.20 |
All other | 26 | 5 | 0.01 | 0.00-0.01 | - | - | - | - | - | - | - | - |
TOTAL g | 24,532 | 4,906 | 5.94 | 5.87-6.02 | 12,370 | 2,474 | 5.87 | 5.77-5.98 | 12,162 | 2,432 | 6.02 | 5.91-6.13 |
Malignant | 14,422 | 2,884 | 3.51 | 3.45-3.56 | 7,902 | 1,580 | 3.76 | 3.68-3.84 | 6,520 | 1,304 | 3.24 | 3.16-3.32 |
Non-Malignant | 10,110 | 2,022 | 2.44 | 2.39-2.49 | 4,468 | 894 | 2.11 | 2.05-2.18 | 5,642 | 1,128 | 2.78 | 2.71-2.85 |
aAnnual average cases are calculated by dividing the five-year total by five.
bRates are per 100,000 and are age-adjusted to the 2000 US standard population.
cICD-O-3 histology and behavior codes: 9470/3, 9471/3, 9472/3, and 9474/3.
dICD-O-3 histology and behavior code: 9473/3.
eICD-O-3 histology and behavior code: 9508/3.
fICD-O-3 histology and behavior codes: 8963/3, 9364/3, 9480/3, 9490/0, 9490/3, 9500/3, 9501/3, and 9502/3.
gRefers to all brain tumors including histologies not presented in this table.
- Counts and rates are not presented when fewer than 16 cases were reported for the specific histology category. Suppressed cases are included in the total counts and rates.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval; NOS, not otherwise specified